vanda pharmaceuticals inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report vanda pharmaceuticals inc  product pipeline review   published by global markets direct product code  published april   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license vanda pharmaceuticals inc  product pipeline review   published april   content info  pages description summary global markets directs vanda pharmaceuticals inc  product pipeline review   provides an overview of the vanda pharmaceuticals incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of vanda pharmaceuticals incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of vanda pharmaceuticals inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of vanda pharmaceuticals incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the vanda pharmaceuticals incs pipeline products reasons to buy evaluate vanda pharmaceuticals incs strategic position with total access to detailed information on its product pipeline assess the growth potential of vanda pharmaceuticals inc in its therapy areas of focus identify new drug targets and therapeutic classes in the vanda pharmaceuticals incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of vanda pharmaceuticals inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of vanda pharmaceuticals inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of vanda pharmaceuticals inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures vanda pharmaceuticals inc snapshot vanda pharmaceuticals inc overview key information key facts vanda pharmaceuticals inc  research and development overview key therapeutic areas vanda pharmaceuticals inc  pipeline review pipeline products by stage of development pipeline products  monotherapy vanda pharmaceuticals inc  pipeline products glance vanda pharmaceuticals inc  late stage pipeline products preregistration productscombination treatment modalities filing rejectedwithdrawn productscombination treatment modalities vanda pharmaceuticals inc  clinical stage pipeline products phase ii productscombination treatment modalities vanda pharmaceuticals inc  drug profiles tasimelteon product description mechanism of action rd progress iloperidone product description mechanism of action rd progress tradipitant product description mechanism of action rd progress vanda pharmaceuticals inc  pipeline analysis vanda pharmaceuticals inc  pipeline products by target vanda pharmaceuticals inc  pipeline products by route of administration vanda pharmaceuticals inc  pipeline products by molecule type vanda pharmaceuticals inc  pipeline products by mechanism of action vanda pharmaceuticals inc  recent pipeline updates vanda pharmaceuticals inc  dormant projects vanda pharmaceuticals inc  discontinued pipeline products discontinued pipeline product profiles iloperidone tasimelteon vanda pharmaceuticals inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables vanda pharmaceuticals inc key information vanda pharmaceuticals inc key facts vanda pharmaceuticals inc  pipeline by indication  vanda pharmaceuticals inc  pipeline by stage of development  vanda pharmaceuticals inc  monotherapy products in pipeline  vanda pharmaceuticals inc  preregistration  vanda pharmaceuticals inc  filing rejectedwithdrawn  vanda pharmaceuticals inc  phase ii  vanda pharmaceuticals inc  pipeline by target  vanda pharmaceuticals inc  pipeline by route of administration  vanda pharmaceuticals inc  pipeline by molecule type  vanda pharmaceuticals inc  pipeline products by mechanism of action  vanda pharmaceuticals inc  recent pipeline updates  vanda pharmaceuticals inc  dormant developmental projects vanda pharmaceuticals inc  discontinued pipeline products  list of figures vanda pharmaceuticals inc  pipeline by top  indication  vanda pharmaceuticals inc  pipeline by stage of development  vanda pharmaceuticals inc  monotherapy products in pipeline  vanda pharmaceuticals inc  pipeline by top  target  vanda pharmaceuticals inc  pipeline by top  route of administration  vanda pharmaceuticals inc  pipeline by top  molecule type  vanda pharmaceuticals inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft overview  about vanda  vanda pharmaceuticals   home  news  careers  contact us about vanda products pipeline partnering investor relations about vandaoverview vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients overview        management        board of directors          home  about vanda  products  pipeline  partnering  investor relations  news  careers  contact us copyright   vanda pharmaceuticals  terms  conditions  privacy policy vanda pharmaceuticals   news  careers  contact us about vanda products pipeline partnering investor relations meet vanda vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients jul   vanda receives negative opinion for marketing authorization from the european medicines agency on fanapt®um for the treatment of schizophrenia jul   vanda pharmaceuticals to announce second quarter  financial results on august   jun   vanda pharmaceuticals announces participation at june  investor conferences read more in the newsroom   home  about vanda  products  pipeline  partnering  investor relations  news  careers  contact us copyright   vanda pharmaceuticals  terms  conditions  privacy policy careers  vanda pharmaceuticals   home  news  careers  contact us about vanda products pipeline partnering investor relations careersoverview thank you for your interest in a career with vanda pharmaceuticals inc please see current opportunities for any detailed job descriptions if you are interested in a position with vanda please submit a cover letter and resume to  if we believe that your credentials match our needs we will contact you for further exploration of your fit with vanda recruiters we do not accept unsolicited résumés from any source other than directly from candidates for consideration please send your company information a copy of your standard search agreement and references to  overview        corporate opportunities        sales opportunities   home  about vanda  products  pipeline  partnering  investor relations  news  careers  contact us copyright   vanda pharmaceuticals  terms  conditions  privacy policy vanda pharmaceuticals inc private company information  bloomberg july    am et biotechnology company overview of vanda pharmaceuticals inc snapshot people company overview vanda pharmaceuticals inc a biopharmaceutical company focuses on the development and commercialization of products for the treatment of central nervous system disorders the company’s marketed products include hetlioz tasimelteon a product for the treatment of nonhour sleepwake disorder and fanapt iloperidone a product for the treatment of schizophrenia its clinical development products include tradipitant vly a small molecule neurokinin receptor antagonist that is under the clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis trichostatin a a small molecule histone deacetylase inhibitor which is in development for the  vanda pharmaceuticals inc a biopharmaceutical company focuses on the development and commercialization of products for the treatment of central nervous system disorders the company’s marketed products include hetlioz tasimelteon a product for the treatment of nonhour sleepwake disorder and fanapt iloperidone a product for the treatment of schizophrenia its clinical development products include tradipitant vly a small molecule neurokinin receptor antagonist that is under the clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis trichostatin a a small molecule histone deacetylase inhibitor which is in development for the treatment of hematologic malignancies and aqw a phase ii alpha nicotinic acetylcholine receptor partial agonist the company markets its products in the united states canada europe union israel and mexico vanda pharmaceuticals inc was incorporated in  and is headquartered in washington the district of columbia detailed description  pennsylvania avenue nwsuite ewashington dc united statesfounded in  employees phone  fax  wwwvandapharmaceuticalscom key executives for vanda pharmaceuticals inc dr mihael h polymeropoulos md founder chief executive officer president and director age  total annual compensation k mr james patrick kelly cfa chief financial officer executive vice president and treasurer age  total annual compensation k mr gian piero reverberi chief commercial officer and senior vice president total annual compensation k mr richard l gulino senior vice president general counsel and secretary age  total annual compensation k compensation as of fiscal year  vanda pharmaceuticals inc key developments vanda pharmaceuticals inc presents at jefferies  global healthcare conference jun  pm jun   vanda pharmaceuticals inc presents at jefferies  global healthcare conference jun  pm venue grand hyatt  e nd st new york new york united states vanda pharmaceuticals inc presents at jmp securities life sciences conference  jun  am jun   vanda pharmaceuticals inc presents at jmp securities life sciences conference  jun  am venue st regis hotel  east  street new york new york united states vanda pharmaceuticals inc reports unaudited consolidated financial results for the first quarter ended march   provides earnings guidance for year  may   vanda pharmaceuticals inc reported unaudited consolidated financial results for the first quarter ended march   for the quarter the company reported total revenues were  compared to  for the first quarter of  loss from operations was  against  last year net loss was  or  per basic and diluted share against  or  per basic and diluted share last year nongaap net loss was  compared with  a year ago nongaap net loss per share basic and diluted was  compared with  a year ago for the year  the company expects net product sales from both hetlioz and fanapt of between  million and  million hetlioz net product sales of between  million and  million fanapt net product sales of between  million and  million nongaap operating expenses excluding cost of good sold of between  million and  million nongaap operating expenses excludes intangible asset amortization expense of  million and stockbased compensation between  million and  million yearend  cash is expected to be between  million and  million similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact vanda pharmaceuticals inc please visit wwwvandapharmaceuticalscom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close product pipeline  vanda pharmaceuticals   home  news  careers  contact us about vanda product pipeline partnering investor relations product pipelineoverview   vanda pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients   fanapt®         hetlioz®         tradipitant         pharmacogenetics         hetliozaccess™         home  about vanda  product pipeline  partnering  investor relations  news  careers  contact us copyright   vanda pharmaceuticals  terms  conditions  privacy policy vnda vanda pharmaceuticals inc  full company report  zackscom join sign in member sign in keep me signed in what does remember me do forgot password create a new account you are being directed to zackstrade a division of lbmz securities and licensed brokerdealer zackstrade and zackscom are separate companies the web link between the two companies is not a solicitation or offer to invest in a particular security or type of security zackstrade does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating indiv idual securities if you wish to go to zackstrade click ok if you do not click cancel ok cancel back to top more vanda pharmaceuticals inc vnda delayed data from nsdq  usd     updated jul    pm et add to portfolio zacks rank sell          style scores d value  d growth  b momentum  f vgm the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores industry rank top  out of  industry medical  biomedical and genetics view all zacks  ranked stocks trades from  this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn about the zacks rank zacks rank home  zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank vanda pharmaceuticals inc vnda quote overview » more research » vanda pharmaceuticals inc vnda full company report company summary vanda pharmaceuticals inc is a biopharmaceutical company focused on the development and commercialization of clinicalstage product candidates for central nervous system disorders it is developing important new medicines to improve the lives of patients it uses new technologies including genetics  genomics to inform our drug discovery our clinical trials and our commercial positioning of our compounds the company has three product candidates in clinical development its lead product candidate iloperidone is a compound for the treatment of schizophrenia  bipolar disorder  is in a phase iii clinical trial for schizophrenia its second product candidate is a compound for the treatment of insomnia  depression which is currently in a phase iii clinical trial for insomnia its third product candidate is a compound for the treatment of excessive sleepiness  is ready for a phase ii clinical trial general information vanda pharmaceuticals inc  pennsylvania ave nw suite e washington dc  phone  fax  web httpwwwvandapharmaceuticalscom email jimkellyvandapharmacom industry medical  biomedical and genetics sector medical fiscal year end december last reported quarter  next eps date  eps information current quarter eps consensus estimate  current year eps consensus estimate  estimated longterm eps growth rate na next eps report date  research for vnda   the zacks equity research reports or zer for short are our inhouse independently produced research reportsthe ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peersthe detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp researching stocks has never been so easy or insightful as with the zer analyst and snapshot reportslearn more about zacks equity research reportssee more zacks equity research reports chart for vnda interactive chart  fundamental charts consensus recommendations current strong buy strong sell   days ago   days ago   days ago  price and volume information zacks rank yesterdays close   week high   week low  beta   day moving average  target price consensus   price change  week   week  ytd   price change relative to sp   week   week  ytd  share information shares outstanding millions  market capitalization millions  short ratio na last split date na dividend information dividend yield  annual dividend  payout ratio na change in payout ratio na last dividend payout  amount na   fundamental ratios pe pe f na trailing  months na peg ratio na eps growth vs previous year  vs previous quarter      sales growth vs previous year  vs previous quarter      price ratios pricebook  pricecash flow na price  sales  roe  na     roa  na     current ratio  na     quick ratio  na     operating margin  na     net margin  na     pretax margin  na     book value  na     inventory turnover  na     debttoequity  na     debt to capital  na     vnda key statistics  vanda pharmaceuticals inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close vanda pharmaceuticals inc nasdaq vnda go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus vanda pharmaceuticals inc after hours  quotes are delayed by  min jul    pm vnda quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description vanda pharmaceuticals inc engages in the research development and commercialization of biopharmaceutical products it intends to treat schizophrenia jet lag disorder atopic dermatitis central nervous system disorders and circadian rhythm sleep disorder its product portfolio includes hetlioz vanda pharmaceuticals inc engages in the research development and commercialization of biopharmaceutical products it intends to treat schizophrenia jet lag disorder atopic dermatitis central nervous system disorders and circadian rhythm sleep disorder its product portfolio includes hetlioz fanapt and tradipitant trichostatin and aqw the company was founded by mihael hristos polymeropoulos and argeris n karabelas in  and is headquartered in washington dc valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title dr mihael hristos polymeropoulos   president chief executive officer  director mr james patrick kelly   chief financial officer treasurer  senior vp dr deepak shripad phadke   vice presidentmanufacturing mr gian reverberi   chief commercial officer  senior vice president mr gunther birznieks   vice presidentbusiness development insider actions – purchase – sale  – number of transactions  date name shares transaction value  richard w dugan director    award at  per share   kenneth m bate director    award at  per share   h thomas watkins director    award at  per share   vincent j milano director    award at  per share   michael f cola director    award at  per share   mihael hristos polymeropoulos president and ceo director    award at  per share   james patrick kelly evp  chief financial officer    award at  per share   gian piero reverberi svp  chief commercial officer    award at  per share   richard l gulino svp general counsel  sec    award at  per share   mihael hristos polymeropoulos president and ceo director    disposition at  per share   james patrick kelly evp  chief financial officer    disposition at  per share   richard l gulino svp general counsel  sec    disposition at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share   gian piero reverberi svp  chief commercial officer    derivativenonderivative trans at  per share   gian piero reverberi svp  chief commercial officer    derivativenonderivative trans at  per share   richard l gulino svp general counsel  sec    derivativenonderivative trans at  per share   richard l gulino svp general counsel  sec    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    disposition at  per share   mihael hristos polymeropoulos president and ceo director    gift at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   deerfield management company lp    disposition at  per share   mihael hristos polymeropoulos president and ceo director    disposition at  per share   james patrick kelly evp  chief financial officer    disposition at  per share   paolo baroldi svp  chief medical officer    disposition at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   mihael hristos polymeropoulos president and ceo director    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   james patrick kelly evp  chief financial officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share   paolo baroldi svp  chief medical officer    derivativenonderivative trans at  per share  newslatestcompanyusvnda marketwatch news on vnda trump’s ‘obamacare lite’ presents opportunities and perils for investors  am march    nigam arora the death of obamacare will bring new opportunities for investors  pm nov    the trading deck sp  extends breakout reclaims the day average  am sept    michael ashbaugh drugmakers jack up prices despite government pressure  pm jan    peter loftus st joe company post holdings may be ready to run  pm sept    the trading deck calmaine foods shares fall on earnings miss  pm dec    wallace witkowski vanda pharmaceuticals stock soars  licensing arbitration settlement  am dec    tomi kilgore sp sets up for santa rally and techs to light up the tree next year  am dec    barbara kollmeyer steelcase shares slide as revenue comes in light  pm dec    wallace witkowski charting the latest market whipsaw  am march    michael ashbaugh what are hedge funds buying these days  pm june    insider monkey  longs and  shorts to watch  pm june    the trading deck vanda pharma shares up on positive trial data  am dec    marketwatchcom vanda pharma up  in premarket  am dec    steve gelsi vanda progress with hourdisorder drug  am oct    marketwatchcom vanda to pay lilly up to  mln  am april    marketwatchcom obama’s spending plan is investors’ cue  am jan    robert powell monday’s biggest gaining and declining stocks  pm nov    robert daniel wednesdays biggest gaining and declining stocks  pm march    marketwatch drug stocks pressured by jj report avanir jumps  pm oct    val brickates kennedy loading more headlines newsnonmarketwatchcompanyusvnda other news on vnda vanda pharmaceuticals an early stage bioscience consideration  pm july    seeking alpha european regulator rejects vandas marketing application for schizophrenia med fanaptum  am july    seeking alpha the zacks analyst blog highlights merck celgene gilead sciences seattle genetics and vanda pharmaceuticals  am july    zackscom  drug stocks well poised to beat q earnings estimates  pm july    zackscom premarket analyst action  healthcare  am june    seeking alpha top analyst upgrades and downgrades alibaba bhp billiton cintas monsanto schlumberger shopify hess western digital and more  am june    wallstcom vanda pharmaceuticals keeps chugging along  am june    seeking alpha vanda pharmaceuticals vnda presents at jmp securities life sciences conference   slideshow  pm june    seeking alpha vanda pharmaceuticals vnda worth a look stock jumps   am june    zackscom vanda several catalysts coming up  am june    seeking alpha vanda pharmaceuticals vnda presents at jefferies  global healthcare conference  slideshow  pm june    seeking alpha premarket analyst action  healthcare  am may    seeking alpha armistice capital llc buys novelion therapeutics inc regeneron pharmaceuticals inc adamas   am may    gurufocuscom commentary on great point partners positions part   am may    seeking alpha birchview capital lp buys yield bioscience inc clovis oncology inc workhorse group inc   pm may    gurufocuscom q vanda pharmaceuticals inc  am may    edgar online  edg  q k vanda pharmaceuticals vnda ceo mihael polymeropoulos on q  results  earnings call transcript  pm may    seeking alpha notable earnings after tuesday’s close  pm may    seeking alpha steven a cohen may have met his match  pm april    barronscom vanda pharmaceuticals vnda presents at oppenheimer th annual healthcare conference  pm march    seeking alpha loading more headlines at a glance vanda pharmaceuticals inc  pennsylvania avenue nw suite e washington district of columbia  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for vnda newspressreleasecompanyusvnda press releases on vnda vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia  am july    pr newswire  prf vanda pharmaceuticals to announce second quarter  financial results on august    am july    pr newswire  prf technical insights on biotech stocks  curis ovascience regulus therapeutics and vanda pharma  am july    pr newswire  prf vanda pharmaceuticals announces participation at june  investor conferences  pm june    pr newswire  prf research reports initiation on biotech stocks  corcept therapeutics curis ovascience and vanda pharma  am may    pr newswire  prf vanda pharmaceuticals reports first quarter  financial results  pm may    pr newswire  prf investor network vanda pharmaceuticals inc to host earnings call  am may    accesswire vanda pharmaceuticals to present at the deutsche bank nd annual health care conference  pm may    pr newswire  prf vanda pharmaceuticals to announce first quarter  financial results on may    pm april    pr newswire  prf vanda and ucsf announce license agreement for cftr activators and inhibitors  pm march    pr newswire  prf how these biotech stocks are faring  corbus pharma advaxis vanda pharma and nivalis therapeutics  am march    pr newswire  prf vanda pharmaceuticals announces participation at march  investor conferences  pm march    pr newswire  prf vanda pharmaceuticals reports fourth quarter  and full year  financial results  pm feb    pr newswire  prf vanda pharmaceuticals to announce fourth quarter and full year  financial results on february    pm jan    pr newswire  prf research reports coverage on biotech stocks  cara therapeutics heat biologics vanda pharma and opexa therapeutics  am jan    pr newswire  prf vanda pharmaceuticals reports preliminary fourth quarter and full year  revenue results and  financial guidance  am jan    pr newswire  prf vanda pharmaceuticals settles fanapt® patent litigation with apotex  pm dec    pr newswire  prf vanda pharmaceuticals announces participation at november  investor conferences  pm nov    pr newswire  prf research reports coverage on biotech stocks  illumina peregrine pharma lexicon pharma and vanda pharma  am nov    pr newswire  prf vanda pharmaceuticals reports third quarter  financial results  pm nov    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  vanda pharmaceuticals inc  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals vanda pharmaceuticals inc  product pipeline review   published apr  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample vanda pharmaceuticals inc  product pipeline review   summary global markets direct’s ‘vanda pharmaceuticals inc  product pipeline review  ’ provides an overview of the vanda pharmaceuticals inc’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of vanda pharmaceuticals inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of vanda pharmaceuticals inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of vanda pharmaceuticals inc’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the vanda pharmaceuticals inc’s pipeline products reasons to buy  evaluate vanda pharmaceuticals inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of vanda pharmaceuticals inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the vanda pharmaceuticals inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of vanda pharmaceuticals inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of vanda pharmaceuticals inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of vanda pharmaceuticals inc and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  vanda pharmaceuticals inc snapshot  vanda pharmaceuticals inc overview  key information  key facts  vanda pharmaceuticals inc  research and development overview  key therapeutic areas  vanda pharmaceuticals inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  vanda pharmaceuticals inc  pipeline products glance  vanda pharmaceuticals inc  late stage pipeline products  preregistration productscombination treatment modalities  filing rejectedwithdrawn productscombination treatment modalities  vanda pharmaceuticals inc  clinical stage pipeline products  phase ii productscombination treatment modalities  vanda pharmaceuticals inc  drug profiles  tasimelteon  product description  mechanism of action  rd progress  iloperidone  product description  mechanism of action  rd progress  tradipitant  product description  mechanism of action  rd progress  vanda pharmaceuticals inc  pipeline analysis  vanda pharmaceuticals inc  pipeline products by target  vanda pharmaceuticals inc  pipeline products by route of administration  vanda pharmaceuticals inc  pipeline products by molecule type  vanda pharmaceuticals inc  pipeline products by mechanism of action  vanda pharmaceuticals inc  recent pipeline updates  vanda pharmaceuticals inc  dormant projects  vanda pharmaceuticals inc  discontinued pipeline products  discontinued pipeline product profiles  iloperidone  tasimelteon  vanda pharmaceuticals inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables vanda pharmaceuticals inc key information  vanda pharmaceuticals inc key facts  vanda pharmaceuticals inc  pipeline by indication   vanda pharmaceuticals inc  pipeline by stage of development   vanda pharmaceuticals inc  monotherapy products in pipeline   vanda pharmaceuticals inc  preregistration   vanda pharmaceuticals inc  filing rejectedwithdrawn   vanda pharmaceuticals inc  phase ii   vanda pharmaceuticals inc  pipeline by target   vanda pharmaceuticals inc  pipeline by route of administration   vanda pharmaceuticals inc  pipeline by molecule type   vanda pharmaceuticals inc  pipeline products by mechanism of action   vanda pharmaceuticals inc  recent pipeline updates   vanda pharmaceuticals inc  dormant developmental projects  vanda pharmaceuticals inc  discontinued pipeline products   list of figures vanda pharmaceuticals inc  pipeline by top  indication   vanda pharmaceuticals inc  pipeline by stage of development   vanda pharmaceuticals inc  monotherapy products in pipeline   vanda pharmaceuticals inc  pipeline by top  target   vanda pharmaceuticals inc  pipeline by top  route of administration   vanda pharmaceuticals inc  pipeline by top  molecule type   vanda pharmaceuticals inc  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports global and europe bcg vaccine market  analysis and outlook to  jul  eu research  pages    code  mrs   this report presents a comprehensive overview of the bcg vaccine market in europe this shares the history data information from  to  and forecast from  to  this report provides a detailed analysis of the market its dynamics structure characteristics main players growth and demand drivers etc as a detailed analysis report it covers all details inside analysis and opinion in bcg vaccine industry this report focus global and europe market it covers details playe read more global onychomycosis tinea unguium drug detailed analysis report  jul  detailed analysis research  pages    code  mrs   this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in onychomycosis tinea unguium drug industry this report fo read more life science analytics  global market outlook  jun  stratistics mrc  pages    code  mrs   according to stratistics mrc the global life science analytics market is expected to grow from  billion in  to reach  billion by  with a cagr of  some of the factors propelling the market growth are raising demand for analytics in sales and marketing applications increasing need of these solutions especially in clinical trials and improvements in technological advancements however lack of skilled professionals huge implementation costs and financial limitations read more chronic kidney disease ckd drugs  global market outlook  jul  stratistics mrc  pages    code  mrs   according to stratistics mrc the global chronic kidney disease ckd drugs market is expected to grow from  billion in  to reach  billion by  with a cagr of  drivers that are shaping the global market include growing incidences of chronic kidney diseases rise in aged population rising incidence of diabetes and obesity related disorders significant unmet requirements and beneficial reimbursement policies on the other hand factors such as intense competition fr read more acaricides  global market outlook  jul  stratistics mrc  pages    code  mrs   according to stratistics mrc the global acaricides market is expected to grow from  million in  to reach  million by  with a cagr of  high demand for meat dairy products and crops growth in crop protection industry and rise in productivity are some of the factors propelling the market growth however increase in cost alternative acaricides sources and regulatory restrictions are the factors suppressing the market on the other hand expansion of bioactive aca read more global and united states bacillus subtilis depth research report  jul  united states research  pages    code  mrs   this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a depth research report it covers all details inside analysis and opinion in bacillus subtilis industry this report focus united states market it covers details players regions product type and other details as following major companies bayer germany basf germany tonglu huifeng china kernel biotech china w read more global bacterial vaginosis drug market rport  jun  bisreport  pages    code  mrs   global bacterial vaginosis drug market report  full report  multi license section  section price as below page  chart and figure  publisher bisreport delivery time  hour contact salesbisreportcom phone  with the slowdown in world economic growth the bacterial vaginosis drug industry has also suffered a certain impact but still maintained a relatively optimistic growth the past four years bacterial vaginosis drug market size to maintain read more global alzheimers disease drug market rport  jun  bisreport  pages    code  mrs   global alzheimer’s disease drug market report  full report  multi license section  section price as below page  chart and figure  publisher bisreport delivery time  hour contact salesbisreportcom phone  with the slowdown in world economic growth the alzheimer’s disease drug industry has also suffered a certain impact but still maintained a relatively optimistic growth the past four years alzheimer’s disease drug market size to maintain read more global protein powder detailed analysis report  jul  detailed analysis research  pages    code  mrs   this report mainly introduces volume and value market share by players by regions by product type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in protein powder industry this report splits protein powder market price size first speciality second speciality protein powder flavors which covers the history data information from  to  and forecast from  to  this report focus glob read more opioidinduced constipation oic  pipeline review h  jul  global markets direct  pages    code  mrs   opioidinduced constipation oic  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide opioidinduced constipation oic  pipeline review h  provides an overview of the opioidinduced constipation oic toxicology pipeline landscape opioids are effective pain relievers but often have the side effect of constipation these medicines affect the gastrointestinal tract in a variety of ways opioids increase the amo read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports vnda stock price  vanda pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern  updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings  updated top  most annoying people you may want to unfriend on facebook  updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states vnda overview compare quotes stock screener earnings calendar sectors nasdaq vnda us nasdaq join td ameritrade find a broker vanda pharmaceuticals inc watchlist createvndaalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee m pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones opinion trump’s ‘obamacare lite’ presents opportunities and perils for investors mar   at  am et by nigam arora the death of obamacare will bring new opportunities for investors nov   at  am et by nigam arora sp  extends breakout reclaims the day average sep   at  am et by michael ashbaugh drugmakers jack up prices despite government pressure jan   at  pm et by peter loftus st joe company post holdings may be ready to run sep   at  pm et by sinisa persich calmaine foods shares fall on earnings miss dec   at  pm et by wallace witkowski vanda pharmaceuticals stock soars  licensing arbitration settlement dec   at  am et by tomi kilgore sp sets up for santa rally and techs to light up the tree next year dec   at  am et by barbara kollmeyer steelcase shares slide as revenue comes in light dec   at  pm et by wallace witkowski charting the latest market whipsaw mar   at  am et by michael ashbaugh what are hedge funds buying these days jun   at  pm et by meena krishnamsetty  longs and  shorts to watch jun   at  pm et by harry boxer vanda pharma shares up on positive trial data dec   at  am et vanda pharma up  in premarket dec   at  am et by steve gelsi vanda progress with hourdisorder drug oct   at  am et vanda to pay lilly up to  mln apr   at  am et obama’s spending plan is investors’ cue jan   at  am et by robert powell monday’s biggest gaining and declining stocks nov   at  pm et by robert daniel wednesdays biggest gaining and declining stocks mar   at  pm et by marketwatch drug stocks pressured by jj report avanir jumps oct   at  pm et by val brickates kennedy steven a cohen may have met his match apr   at  pm et on barrons new drug ads tout serious conditions costly treatments feb   at  pm et on the wall street journal drugmakers raise prices despite criticisms jan   at  pm et on the wall street journal fda mistakenly widened the market for a rare sleep disorder drug petition jun   at  am et on the wall street journal stocks to watch walgreen keurig green mountain dec   at  am et on the wall street journal fda approves hetlioz for sleep disorder in fullyblind patients jan   at  pm et on the wall street journal stocks to watch vanda pharma kimberlyclark cell therapeutics nov   at  am et on the wall street journal stocks to watch herbalife health management potash jul   at  am et on the wall street journal stocks to watch krispy kreme guess omnivision may   at  am et on the wall street journal hot stocks arbitron vanda allstate dec   at  am et on the wall street journal stocks to watch sprint clearwire consol energy oct   at  am et on the wall street journal insidertrading case puts focus on key fda system mar   at  pm et on the wall street journal fda staffer made big gains avoided losses mar   at  pm et on the wall street journal drug news impotence arthritis and schizophrenia jan   at  pm et on the wall street journal mechel oao vanda pharmaceuticals biggest price decliners mtl vnda jul   at  pm et on the wall street journal mechel oao vanda pharmaceuticals biggest price decliners mtl vnda jul   at  pm et on the wall street journal china digital tv holding vanda pharmaceuticals biggest price gainers stv vnda may   at  pm et on the wall street journal aircastle vanda pharmaceuticals biggest price gainers ayr vnda may   at  pm et on the wall street journal crapping out in vegas nov   at  am et on the wall street journal zumiez giii apparel gain dec   at  am et on the wall street journal recent news other news press releases vanda pharmaceuticals an early stage bioscience consideration vanda pharmaceuticals an early stage bioscience consideration jul   at  pm et on seeking alpha european regulator rejects vandas marketing application for schizophrenia med fanaptum european regulator rejects vandas marketing application for schizophrenia med fanaptum jul   at  am et on seeking alpha the zacks analyst blog highlights merck celgene gilead sciences seattle genetics and vanda pharmaceuticals the zacks analyst blog highlights merck celgene gilead sciences seattle genetics and vanda pharmaceuticals jul   at  am et on zackscom  drug stocks well poised to beat q earnings estimates the nyse arca pharmaceutical index has risen almost  year to date jul   at  pm et on zackscom premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha top analyst upgrades and downgrades alibaba bhp billiton cintas monsanto schlumberger shopify hess western digital and more the top analyst upgrades downgrades and other research calls from tuesday include alibaba bhp billiton cintas monsanto schlumberger shopify hess and western digital jun   at  am et on wallstcom vanda pharmaceuticals keeps chugging along vanda pharmaceuticals keeps chugging along jun   at  am et on seeking alpha vanda pharmaceuticals vnda presents at jmp securities life sciences conference   slideshow vanda pharmaceuticals vnda presents at jmp securities life sciences conference   slideshow jun   at  pm et on seeking alpha vanda pharmaceuticals vnda worth a look stock jumps  vanda pharmaceuticals inc vnda shares rose over  in the last trading session jun   at  am et on zackscom vanda several catalysts coming up vanda several catalysts coming up jun   at  am et on seeking alpha vanda pharmaceuticals vnda presents at jefferies  global healthcare conference  slideshow vanda pharmaceuticals vnda presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha armistice capital llc buys novelion therapeutics inc regeneron pharmaceuticals inc adamas  armistice capital llc buys novelion therapeutics inc regeneron pharmaceuticals inc adamas pharmaceuticals inc sells acorda therapeutics inc pacira pharmaceuticals inc verifone systems inc may   at  am et on gurufocuscom commentary on great point partners positions part  commentary on great point partners positions part  may   at  am et on seeking alpha birchview capital lp buys yield bioscience inc clovis oncology inc workhorse group inc  birchview capital lp buys yield bioscience inc clovis oncology inc workhorse group inc sells masimo corp oncomed pharmaceuticals inc accuray inc may   at  pm et on gurufocuscom q vanda pharmaceuticals inc q vanda pharmaceuticals inc may   at  am et on edgar online  edg  q k vanda pharmaceuticals vnda ceo mihael polymeropoulos on q  results  earnings call transcript vanda pharmaceuticals vnda ceo mihael polymeropoulos on q  results  earnings call transcript may   at  pm et on seeking alpha notable earnings after tuesday’s close notable earnings after tuesday’s close may   at  pm et on seeking alpha steven a cohen may have met his match apr   at  pm et on barrons vanda pharmaceuticals vnda presents at oppenheimer th annual healthcare conference mar   at  pm et on seeking alpha vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia jul   at  am et on pr newswire  prf vanda pharmaceuticals to announce second quarter  financial results on august   vanda pharmaceuticals to announce second quarter  financial results on august   jul   at  am et on pr newswire  prf technical insights on biotech stocks  curis ovascience regulus therapeutics and vanda pharma technical insights on biotech stocks  curis ovascience regulus therapeutics and vanda pharma jul   at  am et on pr newswire  prf vanda pharmaceuticals announces participation at june  investor conferences vanda pharmaceuticals announces participation at june  investor conferences jun   at  pm et on pr newswire  prf research reports initiation on biotech stocks  corcept therapeutics curis ovascience and vanda pharma research reports initiation on biotech stocks  corcept therapeutics curis ovascience and vanda pharma may   at  am et on pr newswire  prf vanda pharmaceuticals reports first quarter  financial results vanda pharmaceuticals reports first quarter  financial results may   at  pm et on pr newswire  prf investor network vanda pharmaceuticals inc to host earnings call investor network vanda pharmaceuticals inc to host earnings call may   at  am et on accesswire vanda pharmaceuticals to present at the deutsche bank nd annual health care conference vanda pharmaceuticals to present at the deutsche bank nd annual health care conference may   at  pm et on pr newswire  prf vanda pharmaceuticals to announce first quarter  financial results on may   apr   at  pm et on pr newswire  prf vanda and ucsf announce license agreement for cftr activators and inhibitors mar   at  pm et on pr newswire  prf how these biotech stocks are faring  corbus pharma advaxis vanda pharma and nivalis therapeutics mar   at  am et on pr newswire  prf vanda pharmaceuticals announces participation at march  investor conferences mar   at  pm et on pr newswire  prf vanda pharmaceuticals reports fourth quarter  and full year  financial results feb   at  pm et on pr newswire  prf vanda pharmaceuticals to announce fourth quarter and full year  financial results on february   jan   at  pm et on pr newswire  prf research reports coverage on biotech stocks  cara therapeutics heat biologics vanda pharma and opexa therapeutics jan   at  am et on pr newswire  prf vanda pharmaceuticals reports preliminary fourth quarter and full year  revenue results and  financial guidance jan   at  am et on pr newswire  prf vanda pharmaceuticals settles fanapt® patent litigation with apotex dec   at  pm et on pr newswire  prf vanda pharmaceuticals announces participation at november  investor conferences nov   at  pm et on pr newswire  prf research reports coverage on biotech stocks  illumina peregrine pharma lexicon pharma and vanda pharma nov   at  am et on pr newswire  prf vanda pharmaceuticals reports third quarter  financial results nov   at  pm et on pr newswire  prf vanda pharmaceuticals inc vanda pharmaceuticals inc engages in the research development and commercialization of biopharmaceutical products it intends to treat schizophrenia jet lag disorder atopic dermatitis central nervous system disorders and circadian rhythm sleep disorder its product portfolio includes hetlioz fanapt and tradipitant trichostatin and aqw the company was founded by mihael hristos polymeropoulos and argeris n karabelas in  and is headquartered in washington dc see full profile analyst ratings sell under hold over buy number of ratings  full ratings oppenheimer analysts release  best ideas list jun   at  pm et on benzingacom benzingas top upgrades downgrades for may   may   at  am et on benzingacom your cheat sheet for q biotech earnings apr   at  pm et on benzingacom competitors name chg  market cap novartis ag adr  b bristolmyers squibb co  b johnson  johnson  b eli lilly  co  b pfizer inc  b competitor data provided by partner content trending tickers powered by dvax  s  ssti  mo  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience vnda  stock quote for vanda pharmaceuticals inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices vanda pharmaceuticals inc nasdaq vnda us markets closed adchoices  ▼   after hours     july    pm edt delayed  minutes nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news vanda pharmaceuticals an early stage bioscience consideration seeking alpha  days ago european regulator rejects vandas marketing application for schizophrenia med fanaptum seeking alpha  vanda pharma gets negative opinion from european medicines agency on fanaptum nasdaq  briefvanda receives negative opinion for marketing authorization from the ema on fanaptum reuters  company overview of vanda pharmaceuticals inc bloomberg  the zacks analyst blog highlights merck celgene gilead sciences seattle genetics and vanda pharmaceuticals nasdaq  cognitive impairment associated with schizophrenia cias  pipeline review with therapeutic drugs profile  h  sbwirecom  hrs ago in volatile markets do analysts think you should buy vanda pharmaceuticals inc vnda desotoedgecom  day ago walt disney company the dis raised to hold at bidaskclub healthcaremenunet  days ago lowers stake in walt disney company the dis fumbleboardcom  days ago eleven medicines leap closer to eu approval pharma times  days ago one step closer to eu approval realtime business news  days ago vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia pharmiweb  days ago ema backs eight new medicines turns down drugs from nektar  vanda rapsorg  chmp says no to antipsychotic for acute schizophrenia medscape news  vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia prnewswirecom   orphan drugs receive ema thumbsup biopharma dive  vanda pharmaceuticals inc vnda us news money  adchoices adchoices adchoices markets dow dow ▲    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support vnda stock price  vanda pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern  updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings  updated top  most annoying people you may want to unfriend on facebook  updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states vnda overview compare quotes stock screener earnings calendar sectors nasdaq vnda us nasdaq join td ameritrade find a broker vanda pharmaceuticals inc watchlist createvndaalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee m pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones opinion trump’s ‘obamacare lite’ presents opportunities and perils for investors mar   at  am et by nigam arora the death of obamacare will bring new opportunities for investors nov   at  am et by nigam arora sp  extends breakout reclaims the day average sep   at  am et by michael ashbaugh drugmakers jack up prices despite government pressure jan   at  pm et by peter loftus st joe company post holdings may be ready to run sep   at  pm et by sinisa persich calmaine foods shares fall on earnings miss dec   at  pm et by wallace witkowski vanda pharmaceuticals stock soars  licensing arbitration settlement dec   at  am et by tomi kilgore sp sets up for santa rally and techs to light up the tree next year dec   at  am et by barbara kollmeyer steelcase shares slide as revenue comes in light dec   at  pm et by wallace witkowski charting the latest market whipsaw mar   at  am et by michael ashbaugh what are hedge funds buying these days jun   at  pm et by meena krishnamsetty  longs and  shorts to watch jun   at  pm et by harry boxer vanda pharma shares up on positive trial data dec   at  am et vanda pharma up  in premarket dec   at  am et by steve gelsi vanda progress with hourdisorder drug oct   at  am et vanda to pay lilly up to  mln apr   at  am et obama’s spending plan is investors’ cue jan   at  am et by robert powell monday’s biggest gaining and declining stocks nov   at  pm et by robert daniel wednesdays biggest gaining and declining stocks mar   at  pm et by marketwatch drug stocks pressured by jj report avanir jumps oct   at  pm et by val brickates kennedy steven a cohen may have met his match apr   at  pm et on barrons new drug ads tout serious conditions costly treatments feb   at  pm et on the wall street journal drugmakers raise prices despite criticisms jan   at  pm et on the wall street journal fda mistakenly widened the market for a rare sleep disorder drug petition jun   at  am et on the wall street journal stocks to watch walgreen keurig green mountain dec   at  am et on the wall street journal fda approves hetlioz for sleep disorder in fullyblind patients jan   at  pm et on the wall street journal stocks to watch vanda pharma kimberlyclark cell therapeutics nov   at  am et on the wall street journal stocks to watch herbalife health management potash jul   at  am et on the wall street journal stocks to watch krispy kreme guess omnivision may   at  am et on the wall street journal hot stocks arbitron vanda allstate dec   at  am et on the wall street journal stocks to watch sprint clearwire consol energy oct   at  am et on the wall street journal insidertrading case puts focus on key fda system mar   at  pm et on the wall street journal fda staffer made big gains avoided losses mar   at  pm et on the wall street journal drug news impotence arthritis and schizophrenia jan   at  pm et on the wall street journal mechel oao vanda pharmaceuticals biggest price decliners mtl vnda jul   at  pm et on the wall street journal mechel oao vanda pharmaceuticals biggest price decliners mtl vnda jul   at  pm et on the wall street journal china digital tv holding vanda pharmaceuticals biggest price gainers stv vnda may   at  pm et on the wall street journal aircastle vanda pharmaceuticals biggest price gainers ayr vnda may   at  pm et on the wall street journal crapping out in vegas nov   at  am et on the wall street journal zumiez giii apparel gain dec   at  am et on the wall street journal recent news other news press releases vanda pharmaceuticals an early stage bioscience consideration vanda pharmaceuticals an early stage bioscience consideration jul   at  pm et on seeking alpha european regulator rejects vandas marketing application for schizophrenia med fanaptum european regulator rejects vandas marketing application for schizophrenia med fanaptum jul   at  am et on seeking alpha the zacks analyst blog highlights merck celgene gilead sciences seattle genetics and vanda pharmaceuticals the zacks analyst blog highlights merck celgene gilead sciences seattle genetics and vanda pharmaceuticals jul   at  am et on zackscom  drug stocks well poised to beat q earnings estimates the nyse arca pharmaceutical index has risen almost  year to date jul   at  pm et on zackscom premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha top analyst upgrades and downgrades alibaba bhp billiton cintas monsanto schlumberger shopify hess western digital and more the top analyst upgrades downgrades and other research calls from tuesday include alibaba bhp billiton cintas monsanto schlumberger shopify hess and western digital jun   at  am et on wallstcom vanda pharmaceuticals keeps chugging along vanda pharmaceuticals keeps chugging along jun   at  am et on seeking alpha vanda pharmaceuticals vnda presents at jmp securities life sciences conference   slideshow vanda pharmaceuticals vnda presents at jmp securities life sciences conference   slideshow jun   at  pm et on seeking alpha vanda pharmaceuticals vnda worth a look stock jumps  vanda pharmaceuticals inc vnda shares rose over  in the last trading session jun   at  am et on zackscom vanda several catalysts coming up vanda several catalysts coming up jun   at  am et on seeking alpha vanda pharmaceuticals vnda presents at jefferies  global healthcare conference  slideshow vanda pharmaceuticals vnda presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha armistice capital llc buys novelion therapeutics inc regeneron pharmaceuticals inc adamas  armistice capital llc buys novelion therapeutics inc regeneron pharmaceuticals inc adamas pharmaceuticals inc sells acorda therapeutics inc pacira pharmaceuticals inc verifone systems inc may   at  am et on gurufocuscom commentary on great point partners positions part  commentary on great point partners positions part  may   at  am et on seeking alpha birchview capital lp buys yield bioscience inc clovis oncology inc workhorse group inc  birchview capital lp buys yield bioscience inc clovis oncology inc workhorse group inc sells masimo corp oncomed pharmaceuticals inc accuray inc may   at  pm et on gurufocuscom q vanda pharmaceuticals inc q vanda pharmaceuticals inc may   at  am et on edgar online  edg  q k vanda pharmaceuticals vnda ceo mihael polymeropoulos on q  results  earnings call transcript vanda pharmaceuticals vnda ceo mihael polymeropoulos on q  results  earnings call transcript may   at  pm et on seeking alpha notable earnings after tuesday’s close notable earnings after tuesday’s close may   at  pm et on seeking alpha steven a cohen may have met his match apr   at  pm et on barrons vanda pharmaceuticals vnda presents at oppenheimer th annual healthcare conference mar   at  pm et on seeking alpha vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia vanda receives negative opinion for marketing authorization from the european medicines agency on fanaptum™ for the treatment of schizophrenia jul   at  am et on pr newswire  prf vanda pharmaceuticals to announce second quarter  financial results on august   vanda pharmaceuticals to announce second quarter  financial results on august   jul   at  am et on pr newswire  prf technical insights on biotech stocks  curis ovascience regulus therapeutics and vanda pharma technical insights on biotech stocks  curis ovascience regulus therapeutics and vanda pharma jul   at  am et on pr newswire  prf vanda pharmaceuticals announces participation at june  investor conferences vanda pharmaceuticals announces participation at june  investor conferences jun   at  pm et on pr newswire  prf research reports initiation on biotech stocks  corcept therapeutics curis ovascience and vanda pharma research reports initiation on biotech stocks  corcept therapeutics curis ovascience and vanda pharma may   at  am et on pr newswire  prf vanda pharmaceuticals reports first quarter  financial results vanda pharmaceuticals reports first quarter  financial results may   at  pm et on pr newswire  prf investor network vanda pharmaceuticals inc to host earnings call investor network vanda pharmaceuticals inc to host earnings call may   at  am et on accesswire vanda pharmaceuticals to present at the deutsche bank nd annual health care conference vanda pharmaceuticals to present at the deutsche bank nd annual health care conference may   at  pm et on pr newswire  prf vanda pharmaceuticals to announce first quarter  financial results on may   apr   at  pm et on pr newswire  prf vanda and ucsf announce license agreement for cftr activators and inhibitors mar   at  pm et on pr newswire  prf how these biotech stocks are faring  corbus pharma advaxis vanda pharma and nivalis therapeutics mar   at  am et on pr newswire  prf vanda pharmaceuticals announces participation at march  investor conferences mar   at  pm et on pr newswire  prf vanda pharmaceuticals reports fourth quarter  and full year  financial results feb   at  pm et on pr newswire  prf vanda pharmaceuticals to announce fourth quarter and full year  financial results on february   jan   at  pm et on pr newswire  prf research reports coverage on biotech stocks  cara therapeutics heat biologics vanda pharma and opexa therapeutics jan   at  am et on pr newswire  prf vanda pharmaceuticals reports preliminary fourth quarter and full year  revenue results and  financial guidance jan   at  am et on pr newswire  prf vanda pharmaceuticals settles fanapt® patent litigation with apotex dec   at  pm et on pr newswire  prf vanda pharmaceuticals announces participation at november  investor conferences nov   at  pm et on pr newswire  prf research reports coverage on biotech stocks  illumina peregrine pharma lexicon pharma and vanda pharma nov   at  am et on pr newswire  prf vanda pharmaceuticals reports third quarter  financial results nov   at  pm et on pr newswire  prf vanda pharmaceuticals inc vanda pharmaceuticals inc engages in the research development and commercialization of biopharmaceutical products it intends to treat schizophrenia jet lag disorder atopic dermatitis central nervous system disorders and circadian rhythm sleep disorder its product portfolio includes hetlioz fanapt and tradipitant trichostatin and aqw the company was founded by mihael hristos polymeropoulos and argeris n karabelas in  and is headquartered in washington dc see full profile analyst ratings sell under hold over buy number of ratings  full ratings oppenheimer analysts release  best ideas list jun   at  pm et on benzingacom benzingas top upgrades downgrades for may   may   at  am et on benzingacom your cheat sheet for q biotech earnings apr   at  pm et on benzingacom competitors name chg  market cap novartis ag adr  b bristolmyers squibb co  b johnson  johnson  b eli lilly  co  b pfizer inc  b competitor data provided by partner content trending tickers powered by dvax  s  ssti  mo  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  principles facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings principles  flashratings mission is to provide you  the investor  with as much honest and professional research on your investments as possible  we believe its much better to get a multitude of credible opinions on an investment than to arbitrarily follow any single advisor  be it your banker a friend or a tv pundit  flashratings does not provide advice our job is to accurately and objectively report on analysts credible research and opinions the only advice flashratings will ever give you is to absorb as much fundamental research and different opinions as possible and make your own decisions  flashratings favors covering analysts with proven track records but will cover all analysts as long as their research is honest and professional sign up » flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair